Showing results (1-10 of 153) with videos related to
Sort By:
Pageof 16
Der Radiologe|September 3, 1999
[Diagnostic imaging in clinical tumor staging]T Brodowicz, C C ZielinskiCancer Detection and Prevention|November 4, 2000
Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequencesW J Köstler, T Brodowicz, M Hejna, et al.Wiener Klinische Wochenschrift|January 1, 1995
[The significance of adhesion molecules in oncology]A C Budinsky, C Wiltschke, T Brodowicz, et al.International Journal of Cancer|December 17, 1997
Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitroT Brodowicz, C Wiltschke, A C Budinsky, et al.International Journal of Cancer|June 11, 1997
Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitroA C Budinsky, T Brodowicz, C Wiltschke, et al.Urology|July 22, 1998
Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminomaW J Reiter, C Kratzik, T Brodowicz, et al.British Journal of Cancer|August 14, 1998
Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trialC C Zielinski, B Schnack, M Grbovic, et al.Oncology|December 12, 1997
Tissue expression and serum levels of HER-2/neu in patients with breast cancerM Krainer, T Brodowicz, R Zeillinger, et al.Anti-Cancer Drugs|November 18, 2000
Phase II study of second-line oxaliplatin, irinotecan and mitomycin C in patients with advanced or metastatic colorectal cancerM Hejna, W J Köstler, M Raderer, et al.Anti-Cancer Drugs|June 1, 2000
Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancerT Brodowicz, W J Koestler, S Tomek, et al.Pageof 16